Beigene Stock Fundamentals
| 688235 Stock | 181.38 5.38 3.06% |
BeiGene fundamentals help investors to digest information that contributes to BeiGene's financial success or failures. It also enables traders to predict the movement of BeiGene Stock. The fundamental analysis module provides a way to measure BeiGene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BeiGene stock.
At present, BeiGene's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 2.2 B, whereas Tax Provision is forecasted to decline to about 29.8 M. BeiGene | Select Account or Indicator |
BeiGene Company Current Valuation Analysis
BeiGene's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BeiGene Current Valuation | 152.87 B |
Most of BeiGene's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BeiGene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BeiGene has a Current Valuation of 152.87 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
BeiGene Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BeiGene's current stock value. Our valuation model uses many indicators to compare BeiGene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BeiGene competition to find correlations between indicators driving BeiGene's intrinsic value. More Info.BeiGene is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BeiGene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BeiGene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BeiGene Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.BeiGene is currently under evaluation in current valuation category among its peers.
BeiGene Fundamentals
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0958 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 152.87 B | ||||
| Shares Outstanding | 115.06 M | ||||
| Shares Owned By Insiders | 4.16 % | ||||
| Shares Owned By Institutions | 32.72 % | ||||
| Price To Book | 9.76 X | ||||
| Price To Sales | 7.21 X | ||||
| Revenue | 2.46 B | ||||
| Gross Profit | (511.06 M) | ||||
| EBITDA | (5.58 B) | ||||
| Net Income | (881.71 M) | ||||
| Total Debt | 688.37 M | ||||
| Book Value Per Share | 226.72 X | ||||
| Cash Flow From Operations | (1.16 B) | ||||
| Earnings Per Share | (4.58) X | ||||
| Target Price | 196.06 | ||||
| Number Of Employees | 10.6 K | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 169.46 B | ||||
| Total Asset | 5.81 B | ||||
| Retained Earnings | (7.96 B) | ||||
| Working Capital | 2.39 B | ||||
| Net Asset | 5.81 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 2.5 B | 1.3 B | |
| Cost Of Revenue | 379.9 M | 304.1 M |
Currently Active Assets on Macroaxis
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.